Composition
- Active ingredients
- IMCIROMAB PENTETATE N/A
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA103634.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Myoscint
- Active substance
- imciromab pentetate
- Dosage form
- Vial
- Applicant
- Centocor Inc
- Status
- Discontinued
- FDA approval
- 3 Jul 1996
- Application
- BLA103634-001